Author:
Kochanowski Brian,Kageki-Bonnert Karina,Pinkerton Elizabeth A.,Dougherty Darin D.,Chou Tina
Abstract
Learning Objectives
After participating in this CME activity, the psychiatrist should be better able to:
• Compare and contrast therapies used in combination with transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for treating MDD.
Background
Noninvasive neuromodulation, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), has emerged as a major area for treating major depressive disorder (MDD). This review has two primary aims: (1) to review the current literature on combining TMS and tDCS with other therapies, such as psychotherapy and psychopharmacological interventions, and (2) to discuss the efficacy, feasibility, limitations, and future directions of these combined treatments for MDD.
Method
This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched three databases: PubMed, PsycInfo, and Cochrane Library. The last search date was December 5, 2023.
Results
The initial search revealed 2,519 records. After screening and full-text review, 58 studies (7 TMS plus psychotherapy, 32 TMS plus medication, 7 tDCS plus psychotherapy, 12 tDCS plus medication) were included.
Conclusions
The current literature on tDCS and TMS paired with psychotherapy provides initial support for integrating mindfulness interventions with both TMS and tDCS. Adding TMS or tDCS to stable doses of ongoing medications can decrease MDD symptoms; however, benzodiazepines may interfere with TMS and tDCS response, and antipsychotics can interfere with TMS response. Pairing citalopram with TMS and sertraline with tDCS can lead to greater MDD symptom reduction compared to using these medications alone. Future studies need to enroll larger samples, include randomized controlled study designs, create more uniform protocols for combined treatment delivery, and explore mechanisms and predictors of change.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference95 articles.
1. Evolution of neuromodulation;Stereotact Func Neurosurg,2005
2. What is neuromodulation?;Neuromodulation,2009
3. Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS;Biol Mood Anxiety Disord,2013
4. Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment resistant;J Psychiatr Res,2015
5. Changing brain networks through non-invasive neuromodulation;Front Hum Neurosci,2018